Guardion Health Sciences, Inc.
GHSI
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 72.90K | 81.10K | 2.60M | 3.34M | 79.60K |
| Total Other Revenue | -- | 81.10K | 340.70K | -- | -- |
| Total Revenue | 72.90K | 81.10K | 2.94M | 3.34M | 79.60K |
| Cost of Revenue | 36.60K | 44.20K | 1.59M | 1.88M | 86.60K |
| Gross Profit | 36.30K | 37.00K | 1.35M | 1.46M | -6.90K |
| SG&A Expenses | 1.40M | 1.43M | 2.04M | 2.22M | 1.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.44M | 1.48M | 3.63M | 4.11M | 1.50M |
| Operating Income | -1.37M | -1.40M | -692.20K | -772.90K | -1.42M |
| Income Before Tax | -2.13M | -4.59M | 424.70K | 372.60K | -1.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.13M | -4.59M | 424.70K | 372.60K | -1.58M |
| Earnings from Discontinued Operations | 12.46M | -152.50K | -- | -- | 407.70K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.32M | -4.75M | 424.70K | 372.60K | -1.17M |
| EBIT | -1.37M | -1.40M | -692.20K | -772.90K | -1.42M |
| EBITDA | -1.36M | -1.39M | -687.30K | -768.00K | -1.42M |
| EPS Basic | 8.04 | -3.71 | 0.34 | 0.29 | -0.93 |
| Normalized Basic EPS | -1.03 | -2.24 | 0.34 | 0.18 | -0.78 |
| EPS Diluted | 8.04 | -3.71 | 0.34 | 0.29 | -0.93 |
| Normalized Diluted EPS | -1.03 | -2.24 | 0.34 | 0.18 | -0.78 |
| Average Basic Shares Outstanding | 1.28M | 1.28M | 1.26M | 1.27M | 1.27M |
| Average Diluted Shares Outstanding | 1.28M | 1.28M | 1.26M | 1.27M | 1.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
